The malaria parasite cyclic GMP-dependent protein kinase plays a central role in blood-stage schizogony

Taylor, H.M., McRobert, L., Grainger, M., Sicard, A., Dluzewski, A.R., Hopp, C.S., Holder, A.A. and Baker, D.A. (2010) The malaria parasite cyclic GMP-dependent protein kinase plays a central role in blood-stage schizogony. Eukaryotic Cell, 9(1), pp. 37-45. (doi: 10.1128/EC.00186-09)

[img]
Preview
Text
Eukaryotic_Cell-2010-Taylor-37-45-1.pdf

879kB

Publisher's URL: http://dx.doi.org/10.1128/EC.00186-09

Abstract

A role for the Plasmodium falciparum cyclic GMP (cGMP)-dependent protein kinase (PfPKG) in gametogenesis in the malaria parasite was elucidated previously. In the present study we examined the role of PfPKG in the asexual blood-stage of the parasite life cycle, the stage that causes malaria pathology. A specific PKG inhibitor (compound 1, a trisubstituted pyrrole) prevented the progression of P. falciparum schizonts through to ring stages in erythrocyte invasion assays. Addition of compound 1 to ring-stage parasites allowed normal development up to 30 h postinvasion, and segmented schizonts were able to form. However, synchronized schizonts treated with compound 1 for ≥6 h became large and dysmorphic and were unable to rupture or liberate merozoites. To conclusively demonstrate that the effect of compound 1 on schizogony was due to its selective action on PfPKG, we utilized genetically manipulated P. falciparum parasites expressing a compound 1-insensitive PfPKG. The mutant parasites were able to complete schizogony in the presence of compound 1 but not in the presence of the broad-spectrum protein kinase inhibitor staurosporine. This shows that PfPKG is the primary target of compound 1 during schizogony and provides direct evidence of a role for PfPKG in this process. Discovery of essential roles for the P. falciparum PKG in both asexual and sexual development demonstrates that cGMP signaling is a key regulator of both of these crucial life cycle phases and defines this molecule as an exciting potential drug target for both therapeutic and transmission blocking action against malaria.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Taylor, Dr Helen and Sicard, Miss Audrey
Authors: Taylor, H.M., McRobert, L., Grainger, M., Sicard, A., Dluzewski, A.R., Hopp, C.S., Holder, A.A., and Baker, D.A.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Eukaryotic Cell
ISSN:1535-9778
ISSN (Online):1535-9786
Published Online:13 November 2009
Copyright Holders:Copyright © 2010, American Society for Microbiology
First Published:First published in Eukaryotic Cell 2010, 9(1):37-45.
Publisher Policy:Paid Open Access

University Staff: Request a correction | Enlighten Editors: Update this record